Marcelo Bonini

Senior Member & Chair

H Lee Moffitt Cancer Center and Research Institute
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

Histones scaffold genomic DNA and regulate access to the transcriptional machinery. However, naturally occurring histone variants can alter histone-DNA interactions, DNA and histone modifications, and the chromatin interactome. Hence, alterations in histone variant deposition can disrupt chromatin, and are increasingly recognized as a way to trigger various disease, including cancer. While significant attention has been placed on the biochemical and functional roles of H2A, H3, and H4 histone variants, the variants of H2B remain largely understudied. Here, we show that H2B variants are dysregulated in breast cancer and that certain variants are associated with specific breast cancer subtypes. HIST1H2BO overexpression (in particular) is more common in Asian, African American/Black, and young female populations and is associated with a worse prognosis. In vitro studies show that H2B1O compacts nucleosome structure. Incorporating H2B1O into chromatin activates pro-inflammatory and oncogenic pathways, induces epithelial-to-mesenchymal transition (EMT), and generates resistance to first-line chemotherapeutic agents. Thus, H2B1O acts much like an onco-histone, with H2B variant expression being a prognostic biomarker for breast cancer and a potential new target for drug therapies to enhance treatment efficacy.

Year:

2026

Lipid metabolism and the serine, one-carbon, glycine (SOG) and methionine pathways are independently and significantly correlated with estrogen receptor–negative breast cancer (ERneg BC). Here, we propose a link between lipid metabolism and ERneg BC through phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme in the de novo serine pathway. We demonstrate that the metabolism of the paradigmatic medium-chain fatty acid octanoic acid leads to a metabolic shift toward the SOG and methionine pathways. PHGDH plays a role in both the forward direction, contributing to the production of S-adenosylmethionine, and the reverse direction, generating the oncometabolite 2-hydroxyglutarate, leading to epigenomic reprogramming and phenotypic plasticity. The methionine cycle is closely linked to the transsulfuration pathway. Consequently, we observe that the shift increases the antioxidant glutathione, which mitigates reactive oxygen species (ROS), enabling survival of a subset of cells that have undergone DNA damage. These metabolic changes contribute to several hallmarks of cancer.

Year:

2025

Collaborators (12)

Peng Gao

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Yuan Luo

Chief AI Officer and Associate Professor

Northwestern University

UNITED STATES
View details

Maxim Frolov

University of Chicago

UNITED STATES
View details

Curtis W. McCloskey

Assistant Professor

UPMC Hillman Cancer Center

UNITED STATES
View details

Daniël Melters

Staff Scientist

National Institutes of Health

UNITED STATES
View details

Rama Khokha

Professor

University of Toronto

CANADA
View details

Elizaveta V Benevolenskaya

Professor

University of Illinois Chicago (UIC)

UNITED STATES
View details

Xiaoling Xuei

Research professor

Indiana University School of Medicine

UNITED STATES
View details

Jonathan D Licht

Van Andel Institute

UNITED STATES
View details

Seema Khan

Professor

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Yvonne Fondufe-Mittendorf

Professor

Van Andel Institute

UNITED STATES
View details

Maria Paula Zappia

Research Assistant Professor

University of Chicago

UNITED STATES
View details